AXIN2 is a non‐redundant regulator of AXIN1 stability and β‐catenin in colorectal cancer cells

Lin Liu,John Silke
DOI: https://doi.org/10.1111/febs.17336
2024-11-28
FEBS Journal
Abstract:Aberrant activation of Wnt signalling leads to human diseases such as cancer. At steady state, the levels of β‐catenin, a key mediator of Wnt signalling output, are tightly controlled by a cytosolic "destruction" complex or degradasome, which consists of APC, AXIN, and the kinases CK1α and GSK3β. By performing quantitative analysis of cellular AXIN protein levels at steady state, in AXIN2 knockout cells and upon tankyrase inhibition (TNKSi), Schmidt et al. revealed a unique role of AXIN2 in regulating the total AXIN pool (TAP) and Wnt/β‐catenin signalling activity, which has important clinical ramifications. Comment on: https://doi.org/10.1111/febs.17226. AXIN proteins are major components of the β‐catenin destruction complex or degradasome, which limits β‐catenin nuclear translocation and Wnt signalling activation at steady state. Schmidt et al. performed quantitative analysis of cellular AXIN protein levels in human colorectal cancer cells and revealed that AXIN2 plays a non‐redundant role in regulating the total AXIN pool and Wnt/β‐catenin signalling activity. Tankyrase (TNKS) inhibitors failed to inhibit Wnt/β‐catenin signalling in AXIN2 knockout cells, suggesting that AXIN2 is essential for TNKS inhibitors to function. Mechanistically, the authors show that AXIN2 recruits TNKS to AXIN1 and promotes TNKS‐mediated degradation of AXIN1. These findings may have important implications for anti‐cancer therapy by TNKS small molecule inhibitors.
biochemistry & molecular biology
What problem does this paper attempt to address?